Skip to content
Recall Observatory FDA recall evidence

Device product

MYLA Versions: 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2, part of the VIRTUO System

Z-0084-2022

September 02, 2021

Class II

Product summary

Firm
BioMerieux SA
Event
Event 88658
Status
Terminated
Classification
Class II
Quantity
542 units
Official record key
device-enforcement:Z-0084-2022

Official wording

Reason: Under certain conditions, there is a risk for a false negative result.

Code information: MYLA Software version 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2

Distribution pattern: Worldwide distribution - US Nationwide distribution and the countries of Austria, Australia, Belgium, Canada, Switzerland, Chile, Columbia, Czech Republic, Denmark, Germany, Spain, Finland, France, United Kingdom, Guadeloupe, Hong Kong, Canary Islands, Ireland, India, Italy, Japan, South Korea, The Netherlands, Norway, Poland, Portugal, Sweden, Singapore, South Africa.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Under certain conditions, there is a risk for a false negative result.